• Join SITC
  • Renew
Make a Gift
Skip to main content (Press Enter).
Sign in
Skip auxiliary navigation (Press Enter).
  • Subscribe
Society for Immunotherapy of Cancer (SITC) logo. This will take you to the homepage
Society for Immunotherapy of Cancer (SITC) logo. This will take you to the homepage
Skip main navigation (Press Enter).
  • Educational & Scientific Programs
      • ConnectED
      • Advances in Cancer Immunotherapy™
      • Collaborative Education Programs
      • 2023 Spring Scientific
      • Workshops
      • Tumor Immune Microenvironment: A Holistic Approach
      • Surfaceome Virtual Workshop
      • Bispecific T cell Engagers Virtual Workshop
      • Cytokines in Cancer Immunotherapy Virtual Workshop
      • Call for Proposals
      • Annual Meeting & Pre-Conference Programs
      • 37th Annual Meeting & Pre-Conference Programs
      • Past and Future Annual Meetings & Pre-Conference Programs
      • Cancer Immunotherapy Winter School
      • Patient and Survivor Education and Resources
      • Webinars and Online Education
      • ACI Online Interactive Courses
      • Advances in Cancer Immunotherapy (ACI) Webinars
      • Meet-the-Expert Webinars
      • SITC Clinical Practice Guidelines Online Education
      • SITC-NCI Computational IO Series
      • Targets for Cancer IO: A Deep Dive Series
      • Calendar of Events
  • Professional Development & Training
      • Certificate in Cancer Immunotherapy
      • Meet-the-Expert Program
      • Meet-the-Expert Webinars
      • NCI Immunotherapy Fellowship
      • SITC Sparkathon
      • SITC Sparkathon 2.0 Accelerator
      • Support Sparkathon
      • Other Resources
      • Calendar of Events
      • Path to SITC Leadership
      • Clinical Trials Training and Resources
      • SITC Clinical Immuno-Oncology Network (SCION) Workshop
      • Maximizing the Value of Phase III Trials in Immuno-Oncology
      • Professional Interest Communities
      • Fellowships
      • Women in Cancer Immunotherapy Network (WIN)
      • Women in Cancer Immunotherapy Network 2022
      • Women in SITC Community
      • Early Career Scientist (ECS) Committee
  • Publications & Guidelines
      • Journal for ImmunoTherapy of Cancer
      • About JITC
      • Become a Reviewer
      • For Authors
      • From the Editors
      • JITC Collections and Special Issues
      • SITC Immunotherapy Books
      • SITC's Guide to Managing Immunotherapy Toxicity Textbook
      • Cancer Immunotherapy Principles and Practice Textbook, 2nd Ed.
      • SITC Clinical Practice Guidelines
      • Clinical Practice Guidelines
      • Clinical Practice Guidelines Online Education
      • Clinical Practice Guidelines Mobile App
      • Patient Resource Guides
  • Policy & Advocacy
      • Advocacy
      • Crisis in Clinical Research
      • Global Immunotherapy Access
      • Government Relations
      • Quality and Value
      • Patient & Survivor Education & Resources
  • Membership
      • Academy of Immuno-Oncology
      • About the Academy
      • Nomination and Selection
      • Members Only
      • SITC Member Directory
      • Renew Your Membership
      • Become a SITC Member
      • Membership Benefits
      • Submit an Application
      • Membership Categories
      • Volunteer
      • Volunteer with SITC
      • Connect-a-Colleague
      • Corporate Membership
      • Path to SITC Leadership
  • Support SITC
      • The Forward Fund
      • Moving the Field Forward
      • Making a Difference
      • Named Funds and Awards
      • Early Career Scientist Awards
      • Richard V. Smalley Memorial Award and Lectureship
      • Steven A. Rosenberg Scholars Award
      • Technology Awards
      • Martin "Mac" Cheever Travel Award Fund
      • Sparkathon 2.0 Accelerator
      • The CheckPoints: SITC’s House Band
      • Ways to Make a Gift
      • Donate
      • Stocks and Securities
      • Estate and Planned Gifts
      • Corporate Support and Giving Opportunities
      • Corporate Giving Opportunities
      • Corporate Membership
      • Educational Grants
      • Sponsorship & Advertising
      • SITC Merchandise
      • Honor and Memorial Gifts
      • Make a Gift in Honor of a Loved One
      • Make a Gift in Memory of a Loved One
      • Our Donors and Supporters
      • 2022 SITC Supporters
      • Forward Fund Donors
  • About SITC
      • Awards and Recognition
      • Committees, Task Forces and Professional Interest Communities
      • Partnerships
      • SITC Policies
      • Board of Directors
      • Elevating a Rich Oncology Community: SITC’s DEI Strategic Plan
      • Media Room
      • SITC Press Releases
      • Scientific Meeting Highlights from SITC
      • Immune Monitor Archive
      • JITC Digest Archive
      • Cancer Immunotherapy Month
      • Career Connections
      • Mission & Vision
      • Contact SITC
      • SITC Staff
      • Contact Us
  • The Connect Community
      • Create Account
      • My Profile
      • My Communities
      • My Libraries
      • The Sentinel - SITC Blog

iSBTc 25th Annual Meeting

Annual Meeting Main Page  |  Annual Meeting Highlights  |   Program Purpose  |  Presentation Slides & Schedule
Faculty  |  Abstracts  |  Hot Topic Symposium |  Hot Topic Highlights  |  Award Recipients
Early Career Scientists  |   Session Goals  |  Final Program  |  Photos   |  Meeting Summary


      October 2 - 4, 2010
      Hyatt Regency Washington on Capitol Hill
      Washington, D.C.
 

2010 Final ProgramThe iSBTc Annual Meeting allows for the exchange of the most cutting edge preclinical and clinical data on the use of biological therapies in cancer. Sessions on clinical trial design, navigating the regulatory issues, as well as the most current concepts on biologic and immunotherapeutic approaches will occur, allowing investigators to share and build on their data.

iSBTc’s strength lies in its history of organizing successful Annual Meetings which assemble key constituents and produce scientifically significant discussions regarding relevant issues in biological therapy for the treatment of cancer. By addressing and fulfilling these needs, iSBTc is enabling productive, effective, and efficient research and therapy with biologic and immunologic agents. Ultimately this scientific exchange and collaborative environment will lead to better cancer patient outcomes.

Program Materials

Download Final Program Download 2010 Abstracts


Intended Audience

Basic and clinical investigators involved in cancer research comprising members of academic, pharmaceutical, and regulatory agencies including basic scientists, clinicians, graduate students and post-doctoral fellows, as well as allied health professionals.

Program Goals

To facilitate enhancing physician/researcher competence and performance in their daily activities, the iSBTc Annual Meeting provides a forum to:

  • Promote scientific exchange of most recent advances and data in the biological treatment of cancer, as well as advances in basic cancer biology with relevance for anti-tumor immunity.
  • Promote the identification of new applications incorporating these advances and explore their potential for impact on treatment outcomes and personalized therapy.
  • Discuss the latest clinical developments regarding application of biologic approaches and establish dialogue between academia, government and industry regarding implications as well as future directions.
  • Educate and provide perspective to the audience on the broad range of scientific developments in cancer and biological approaches to therapy.
  • Discuss therapeutic approaches to cancer immunotherapy including: vaccination strategies including combinations of vaccines and molecularly targeted therapies, adoptive T cell transfer, dendritic cells, innate/adaptive immune interplay, countering negative regulation and immune cell trafficking to tumor microenvironment.
  • Integrate novel clinical trial designs, new endpoints and new strategies for response assessment into clinical trials evaluating biologic therapy of cancer.
  • Explore the role of biologic therapy in human cancers, in particular melanoma, colorectal, prostate and breast cancers, and hematologic malignancies.

Expected Learner Outcomes

Upon completion of this meeting, participants will be able to:

  • Summarize the most recent advances in cancer biology, how they intersect with the immune system, and how these considerations are relevant for the biologic therapy of cancer.
  • Establish how to solidify collaborations among the various members of academia, industry and clinical practices to initiate clinical evaluation of these advances in more efficient trials.
Organizers

Pierre Coulie, MD, PhD
de Duve Institute and University of Louvain

Elizabeth M. Jaffee, MD
Johns Hopkins University

Pawel Kalinski, MD, PhD
University of Pittsburgh Cancer Institute

Vernon K. Sondak, MD
H. Lee Moffitt Cancer Center

The iSBTc 25th Annual Meeting is a non-accredited continuing medical education event. No credits are offered for physician participation in this educational program.



Membership Links

Join

Renew

Member Directory

My Profile

Get Involved

Email Sign-up

Volunteer

Support SITC

Contact Us

© 2023 Society for Immunotherapy of Cancer (SITC). All rights reserved.
555 East Wells Street, Suite 1100 | Milwaukee, WI | 53202-3823 | USA

Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: info@sitcancer.org

Powered by Higher Logic